QQ客服 官方微博 反馈留言

	A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway
	Gong Chenyuan[1]; Xu Chong[2]; Ji Lili[3]; Wang Zhengtao[4]
刊名	Bioscience trends
	2013
卷号	7页码:230-6
ISSN号	1881-7823
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2290591
专题	上海大学
作者单位	The MOE Key Laboratory for Standardization of Chinese Medicines and The Shanghai Key Laboratory for Compound Chinese medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
推荐引用方式 GB/T 7714	Gong Chenyuan[1],Xu Chong[2],Ji Lili[3],et al. A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway[J]. Bioscience trends,2013,7:230-6.
APA	Gong Chenyuan[1],Xu Chong[2],Ji Lili[3],&Wang Zhengtao[4].(2013).A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway.Bioscience trends,7,230-6.
MLA	Gong Chenyuan[1],et al."A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway".Bioscience trends 7(2013):230-6.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。